<VariationArchive VariationID="3889" VariationName="NM_000520.6(HEXA):c.1274_1277dup (p.Tyr427fs)" VariationType="Duplication" Accession="VCV000003889" Version="132" RecordType="classified" NumberOfSubmissions="32" NumberOfSubmitters="32" DateLastUpdated="2024-07-29" DateCreated="2015-10-05" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18928" VariationID="3889">
      <GeneList>
        <Gene Symbol="HEXA" FullName="hexosaminidase subunit alpha" GeneID="3073" HGNC_ID="HGNC:4878" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="72340924" stop="72376014" display_start="72340924" display_stop="72376014" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="72635777" stop="72668519" display_start="72635777" display_stop="72668519" Strand="-" />
          </Location>
          <OMIM>606869</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000520.6(HEXA):c.1274_1277dup (p.Tyr427fs)</Name>
      <CanonicalSPDI>NC_000015.10:72346579:GATA:GATAGATA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>15q23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="72346579" stop="72346580" display_start="72346579" display_stop="72346580" variantLength="4" positionVCF="72346579" referenceAlleleVCF="G" alternateAlleleVCF="GGATA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="72638921" stop="72638924" display_start="72638921" display_stop="72638924" variantLength="4" positionVCF="72638920" referenceAlleleVCF="G" alternateAlleleVCF="GGATA" />
      </Location>
      <OtherNameList>
        <Name>1278insTATC</Name>
        <Name>+TATC1278</Name>
      </OtherNameList>
      <ProteinChange>Y427fs</ProteinChange>
      <ProteinChange>Y438fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000520.4" sequenceAccession="NM_000520" sequenceVersion="4" change="c.1274_1277dupTATC">
            <Expression>NM_000520.4:c.1274_1277dupTATC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000520.5" sequenceAccession="NM_000520" sequenceVersion="5" change="c.1274_1277dupTATC">
            <Expression>NM_000520.5:c.1274_1277dupTATC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.72346580_72346583dup" Assembly="GRCh38">
            <Expression>NC_000015.10:g.72346580_72346583dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.72638921_72638924dup" Assembly="GRCh37">
            <Expression>NC_000015.9:g.72638921_72638924dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009017.2" sequenceAccession="NG_009017" sequenceVersion="2" change="g.34597_34600dup">
            <Expression>NG_009017.2:g.34597_34600dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009017.3" sequenceAccession="NG_009017" sequenceVersion="3" change="g.34431_34434dup">
            <Expression>NG_009017.3:g.34431_34434dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000520.6" sequenceAccession="NM_000520" sequenceVersion="6" change="c.1274_1277dup" MANESelect="true">
            <Expression>NM_000520.6:c.1274_1277dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000511.2" sequenceAccession="NP_000511" sequenceVersion="2" change="p.Tyr427fs">
            <Expression>NP_000511.2:p.Tyr427fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318825.2" sequenceAccession="NM_001318825" sequenceVersion="2" change="c.1307_1310dup">
            <Expression>NM_001318825.2:c.1307_1310dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305754.1" sequenceAccession="NP_001305754" sequenceVersion="1" change="p.Tyr438fs">
            <Expression>NP_001305754.1:p.Tyr438fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA325516" DB="ClinGen" />
        <XRef ID="GTR000321634" DB="Genetic Testing Registry (GTR)" />
        <XRef ID="GTR000508973" DB="Genetic Testing Registry (GTR)" />
        <XRef ID="GTR000603988" DB="Genetic Testing Registry (GTR)" />
        <XRef Type="Allelic variant" ID="606869.0001" DB="OMIM" />
        <XRef Type="rs" ID="387906309" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00046" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00058" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00064" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00080" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00104" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000520.6(HEXA):c.1274_1277dup (p.Tyr427fs) AND Tay-Sachs disease" Accession="RCV000004093" Version="113">
        <ClassifiedConditionList TraitSetID="1067">
          <ClassifiedCondition DB="MedGen" ID="C0039373">Tay-Sachs disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-28" SubmissionCount="23">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000520.6(HEXA):c.1274_1277dup (p.Tyr427fs) AND not provided" Accession="RCV000224443" Version="33">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-10-01" SubmissionCount="6">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000520.6(HEXA):c.1274_1277dup (p.Tyr427fs) AND Inborn genetic diseases" Accession="RCV000623223" Version="10">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000520.6(HEXA):c.1274_1277dup (p.Tyr427fs) AND Intellectual disability" Accession="RCV001252517" Version="8">
        <ClassifiedConditionList TraitSetID="17021">
          <ClassifiedCondition DB="MedGen" ID="C3714756">Intellectual disability</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-01-01" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000520.6(HEXA):c.1274_1277dup (p.Tyr427fs) AND multiple conditions" Accession="RCV001250227" Version="7">
        <ClassifiedConditionList TraitSetID="14141">
          <ClassifiedCondition DB="MedGen" ID="C0039373">Tay-Sachs disease</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268275">Tay-Sachs disease, variant AB</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-28" NumberOfSubmissions="32" NumberOfSubmitters="32" DateCreated="2015-10-05" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general" Abbrev="ACMG, 2015">
          <ID Source="PubMed">25741868</ID>
          <ID Source="pmc">4544753</ID>
          <ID Source="DOI">10.1038/gim.2015.30</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10571007</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11463833</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1301938</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1307230</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14727180</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16088929</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16352452</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1830584</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1833974</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20672374</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21228398</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22441121</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22723944</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22789865</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2294750</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22975760</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23852624</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24374108</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24518553</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24940364</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25287655</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25557439</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27033294</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27896118</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27959697</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2824459</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2848800</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28503624</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">36135330</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8230592</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8352284</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8488832</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8490625</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301397</ID>
          <ID Source="BookShelf">NBK1218</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1067" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6027" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GM2 gangliosidosis, type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HexA deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hexosaminidase alpha-subunit deficiency (variant B)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sphingolipidosis, Tay-Sachs</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hexosaminidase A Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tay-Sachs disease</ElementValue>
                <XRef ID="Tay+Sachs+disease/7008" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010100" DB="MONDO" />
                <XRef ID="111385000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TSD</ElementValue>
                <XRef Type="MIM" ID="272800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7737" />
                <XRef ID="7737" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">HEXA disorders are best considered as a disease continuum based on the amount of residual beta-hexosaminidase A (HEX A) enzyme activity. This, in turn, depends on the molecular characteristics and biological impact of the HEXA pathogenic variants. HEX A is necessary for degradation of GM2 ganglioside; without well-functioning enzymes, GM2 ganglioside builds up in the lysosomes of brain and nerve cells. The classic clinical phenotype is known as Tay-Sachs disease (TSD), characterized by progressive weakness, loss of motor skills beginning between ages three and six months, decreased visual attentiveness, and increased or exaggerated startle response with a cherry-red spot observable on the retina followed by developmental plateau and loss of skills after eight to ten months. Seizures are common by 12 months with further deterioration in the second year of life and death occurring between ages two and three years with some survival to five to seven years. Subacute juvenile TSD is associated with normal developmental milestones until age two years, when the emergence of abnormal gait or dysarthria is noted followed by loss of previously acquired skills and cognitive decline. Spasticity, dysphagia, and seizures are present by the end of the first decade of life, with death within the second decade of life, usually by aspiration. Late-onset TSD presents in older teens or young adults with a slowly progressive spectrum of neurologic symptoms including lower-extremity weakness with muscle atrophy, dysarthria, incoordination, tremor, mild spasticity and/or dystonia, and psychiatric manifestations including acute psychosis. Clinical variability even among affected members of the same family is observed in both the subacute juvenile and the late-onset TSD phenotypes.</Attribute>
                <XRef ID="NBK1218" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301397</ID>
                <ID Source="BookShelf">NBK1218</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <XRef ID="845" DB="Orphanet" />
              <XRef ID="C0039373" DB="MedGen" />
              <XRef ID="MONDO:0010100" DB="MONDO" />
              <XRef Type="MIM" ID="272800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="14141" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6027" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GM2 gangliosidosis, type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HexA deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hexosaminidase alpha-subunit deficiency (variant B)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sphingolipidosis, Tay-Sachs</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hexosaminidase A Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tay-Sachs disease</ElementValue>
                <XRef ID="Tay+Sachs+disease/7008" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010100" DB="MONDO" />
                <XRef ID="111385000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TSD</ElementValue>
                <XRef Type="MIM" ID="272800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7737" />
                <XRef ID="7737" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">HEXA disorders are best considered as a disease continuum based on the amount of residual beta-hexosaminidase A (HEX A) enzyme activity. This, in turn, depends on the molecular characteristics and biological impact of the HEXA pathogenic variants. HEX A is necessary for degradation of GM2 ganglioside; without well-functioning enzymes, GM2 ganglioside builds up in the lysosomes of brain and nerve cells. The classic clinical phenotype is known as Tay-Sachs disease (TSD), characterized by progressive weakness, loss of motor skills beginning between ages three and six months, decreased visual attentiveness, and increased or exaggerated startle response with a cherry-red spot observable on the retina followed by developmental plateau and loss of skills after eight to ten months. Seizures are common by 12 months with further deterioration in the second year of life and death occurring between ages two and three years with some survival to five to seven years. Subacute juvenile TSD is associated with normal developmental milestones until age two years, when the emergence of abnormal gait or dysarthria is noted followed by loss of previously acquired skills and cognitive decline. Spasticity, dysphagia, and seizures are present by the end of the first decade of life, with death within the second decade of life, usually by aspiration. Late-onset TSD presents in older teens or young adults with a slowly progressive spectrum of neurologic symptoms including lower-extremity weakness with muscle atrophy, dysarthria, incoordination, tremor, mild spasticity and/or dystonia, and psychiatric manifestations including acute psychosis. Clinical variability even among affected members of the same family is observed in both the subacute juvenile and the late-onset TSD phenotypes.</Attribute>
                <XRef ID="NBK1218" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301397</ID>
                <ID Source="BookShelf">NBK1218</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <XRef ID="845" DB="Orphanet" />
              <XRef ID="C0039373" DB="MedGen" />
              <XRef ID="MONDO:0010100" DB="MONDO" />
              <XRef Type="MIM" ID="272800" DB="OMIM" />
            </Trait>
            <Trait ID="5205" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Gm2-gangliosidosis, ab variant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tay-Sachs disease, variant AB</ElementValue>
                <XRef ID="Gm2-gangliosidosis%2C+ab+variant/8491" DB="Genetic Alliance" />
                <XRef ID="71253000" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17406" />
                <XRef ID="17406" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Acute infantile GM2 activator deficiency is a neurodegenerative disorder in which infants, who are generally normal at birth, have progressive weakness and slowing of developmental progress between ages four and 12 months. An ensuing developmental plateau is followed by progressively rapid developmental regression. By the second year of life decerebrate posturing, difficulty in swallowing, and worsening seizures lead to an unresponsive vegetative state. Death usually occurs between ages two and three years.</Attribute>
                <XRef ID="NBK583219" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36007105</ID>
                <ID Source="BookShelf">NBK583219</ID>
              </Citation>
              <XRef ID="309246" DB="Orphanet" />
              <XRef ID="C0268275" DB="MedGen" />
              <XRef ID="MONDO:0010099" DB="MONDO" />
              <XRef Type="MIM" ID="272750" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="17021" Type="Finding" ContributesToAggregateClassification="false">
            <Trait ID="22261" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Intellectual functioning disability</ElementValue>
                <XRef ID="228156007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability</ElementValue>
                <XRef ID="HP:0001249" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0001071" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">intellectual disabilities</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Intellectual developmental disorder</ElementValue>
                <XRef ID="110359009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MR</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11963" />
                <XRef ID="11963" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="Retired, AAN/CNS, 2011">
                <ID Source="PubMed">21956720</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2021">
                <ID Source="PubMed">34211152</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2021">
                <ID Source="PubMed">34131312</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAP, 2014">
                <ID Source="PubMed">25157020</ID>
              </Citation>
              <XRef ID="C3714756" DB="MedGen" />
              <XRef ID="D008607" DB="MeSH" />
              <XRef ID="MONDO:0001071" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001249" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0000730" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001267" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001286" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002122" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002192" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002316" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002382" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002386" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002402" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002458" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002482" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002499" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002543" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003767" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006833" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007154" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007176" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007180" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="459193" SubmissionDate="2015-09-15" DateLastUpdated="2015-10-05" DateCreated="2015-10-05">
        <ClinVarSubmissionID localKey="NM_000520.4(HEXA):c.1274_1277dup|Tay-Sachs disease" />
        <ClinVarAccession Accession="SCV000247559" DateUpdated="2015-10-05" DateCreated="2015-10-05" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-08-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.4:c.1274_1277dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Tay-Sachs disease</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="966546" SubmissionDate="2016-04-12" DateLastUpdated="2016-01-31" DateCreated="2016-01-31">
        <ClinVarSubmissionID localKey="c.1274_1277dup" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000494223" DateUpdated="2016-01-31" DateCreated="2016-01-31" Type="SCV" Version="1" SubmitterName="Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics" OrgID="505565" OrganizationCategory="other" OrgAbbreviation="FRIGE - IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-09-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22723944</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23852624</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27896118</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Indian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Tissue>Blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <Description>Polymerase Chain Reaction followed by bi-directional Sanger sequencing was performed covering all exons and exon-intron boundaries of the HEXA gene.</Description>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">B-5539</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Developmental regression</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002376" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Cherry red spot of the macula</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0010729" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Muscular hypotonia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001252" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Seizures</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Hyperacusis</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0010780" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Hepatomegaly</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002240" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">EEG abnormality</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002353" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Abnormal thalamic MRI signal intensity</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0012696" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000520.4:Exon 11</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Y427IfsX5</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.4:c.1274_1277dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Molecular_analysis_of_HEXA_gene</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1048752" SubmissionDate="2016-08-10" DateLastUpdated="2017-04-03" DateCreated="2017-04-03">
        <ClinVarSubmissionID localKey="2016_35|OMIM:272800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000538041" DateUpdated="2017-04-03" DateCreated="2017-04-03" Type="SCV" Version="1" SubmitterName="Knight Diagnostic Laboratories, Oregon Health and Sciences University" OrgID="505542" OrganizationCategory="laboratory" OrgAbbreviation="KDL-OHSU" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-09-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1274_1277dupTATC, (p.Tyr427Ilefs*5) is a known frameshift variant that has been shown to result in the absence of mRNA. To that effect, the majority of pathogenic variants in the Ashkenazi Jewish TSD are null alleles, making it a common mechanism of disease. Moreover, this 4 basepair insertion variant has been reported in the majority of affected individuals of Ashkenazi Jewish ancestry (Myerowitz and Costigan, 1988), and has not been seen in the normal population databases (1000 Genomes, ExAc, and Exome Sequencing Project [ESP]). In summary, this variant is best classified as a recessive pathogenic variant for Tay-Sachs disease.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.4:c.1274_1277dupTATC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-NextGen</StudyName>
        <SubmissionNameList>
          <SubmissionName>CSER-NextGen-1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1139224" SubmissionDate="2017-07-06" DateLastUpdated="2017-07-08" DateCreated="2017-07-08">
        <ClinVarSubmissionID localKey="15:72638920:G" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000584094" DateUpdated="2017-07-08" DateCreated="2017-07-08" Type="SCV" Version="1" SubmitterName="HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology" OrgID="505530" OrganizationCategory="laboratory" OrgAbbreviation="HA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-07-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">HA_assertions_20150911</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/zo9ynrar/ha_assertions_20150911.pdf</URL>
            <CitationText>HA_assertions_20150911.pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">15:72638920:G:00035</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">15:72638920:G:00443D</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">15:72638920:G:00443C</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="GGATA" referenceAllele="G" start="72638920" stop="72638920" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-HudsonAlpha</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB2844653</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1789760" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="628885" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000914692" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24518553</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1307230</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24940364</ID>
          </Citation>
          <Comment>The HEXA c.1274_1277dupTATC (p.Tyr427IlefsTer5) variant results in a frameshift and is predicted to result in premature termination of the protein. Across a selection of the available literature, the p.Tyr427IlefsTer5 variant has been identified in eight probands in a homozygous state, two probands in a compound heterozygous state and in five probands with unknown zygosity (Myerowitz et al. 1988; McDowell et al. 1992; Jamali et al. 2014; Sheth et al. 2014). The c.1274_1277dupTATC (p.Tyr427IlefsTer5) the most common HEXA variant in the Ashkenazi Jewish population and accounts for approximately 80% of variant HEXA alleles in this population (Kaback et al. 2011). Segregation of the variant with the disease has been shown in at least two families (Myerowitz et al. 1988). The variant was found in 69 of 2238 controls in a heterozygous state and is reported at a frequency of 0.00157 in the European American population of the Exome Sequencing Project. Due to the potential impact of frameshift variants, the p.Tyr427IlefsTer5 variant is classified as pathogenic for hexosaminidase A deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="GGATA" referenceAllele="G" start="72638920" stop="72638920" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.4:c.1274_1277dupTATC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1393311" SubmissionDate="2019-03-21" DateLastUpdated="2018-04-09" DateCreated="2018-04-09">
        <ClinVarSubmissionID localKey="69392912|Orphanet:ORPHA845" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000712205" DateUpdated="2018-04-09" DateCreated="2018-04-09" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24518553</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1301938</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16088929</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22441121</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25557439</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27033294</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27959697</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25287655</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22789865</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20672374</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21228398</ID>
          </Citation>
          <Comment>The p.Tyr427IlefsX5 (NM_000520.4 c.1274_1277dupTATC) variant in HEXA is a common pathogenic variant that has been reported in many compound heterozygous and hom ozygous individuals with Tay-Sachs disease (Myerowitz 1988, Montalvo 2005, Scott 2010, Gort 2012, Zampieri 2012, Jamail 2014). It has been reported in ClinVar ( Variation ID#3889) as pathogenic by multiple laboratories. This variant has been identified in 1.3% (135/10152) of Ashkenazi Jewish chromosomes and 0.03% (48/12 6682) of European chromosomes by the Genome Aggregation Database (gnomAD, http:/ /gnomad.broadinstitute.org; dbSNP rs387906309). Although this variant has been s een in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 427 and le ads to a premature termination codon 5 amino acids downstream. This alteration i s then predicted to lead to a truncated or absent protein. Biallelic loss of fun ction in the HEXA gene is an established disease mechanism for Tay-Sachs disease . In summary, this variant meets criteria to be classified as pathogenic for Ta y-Sachs disease in an autosomal recessive manner based upon a predicted null eff ect and its biallelic occurrence in individuals with this disease.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000520.4:EXON 11</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.72638920_72638921insGATA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Tay-Sachs disease</ElementValue>
            </Name>
            <XRef DB="Orphanet" ID="ORPHA845" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348977</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2253889" SubmissionDate="2020-01-06" DateLastUpdated="2020-01-12" DateCreated="2020-01-12">
        <ClinVarSubmissionID localKey="NM_000520.4:c.1274_1277dupTATC|Tay-Sachs disease" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001142451" DateUpdated="2020-01-12" DateCreated="2020-01-12" Type="SCV" Version="1" SubmitterName="Reproductive Health Research and Development, BGI Genomics" OrgID="507058" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-06">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>NM_000520.4:c.1274_1277dupTATC in the HEXA gene has an allele frequency of 0.013 in Ashkenazi Jewish subpopulation in the gnomAD database. This variant is located at the 11th exon (14 exons in the NM_000520.4 transcript), therefore, it is predicted to lead nonsense-mediated mRNA decay. The c.1274_1277dupTATC (p.Tyr427Ilefs*5) variant has been reported multiple times and is determiend as the most common disease-causing variant in the Ashkenazi Jewis (PMID: 20672374). Taken together, we interprete this variant as Pathogenic/Likely pathogenic. ACMG/AMP criteria applied: PVS1; PS4; PP4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.4:c.1274_1277dupTATC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Tay-Sachs disease</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6087587</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2354320" SubmissionDate="2020-06-18" DateLastUpdated="2020-07-06" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey="505|OMIM:272800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001193865" DateUpdated="2020-07-06" DateCreated="2020-04-06" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000485123" DateChanged="2020-07-02" Version="2">
            <Comment Type="MergeComment">SCV000485123 was merged into SCV001193865 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2019-10-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">2848800</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1307230</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1830584</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11463833</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14727180</ID>
          </Citation>
          <Comment>NM_000520.4(HEXA):c.1274_1277dupTATC(Y427Ifs*5) is classified as pathogenic in the context of hexosaminidase A deficiency. Please note that the Y427Ifs*5 variant is associated with Tay-Sachs disease. Sources cited for classification include the following: PMID 2848800, 1307230, 1830584, 11463833, and 14727180. Classification of NM_000520.4(HEXA):c.1274_1277dupTATC(Y427Ifs*5) is based on the following criteria: The variant causes a premature termination codon that is expected to be targeted by nonsense-mediated mRNA decay and is reported in individuals with the relevant phenotype. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/vlxza0ea/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2019_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="GGATA" referenceAllele="G" start="72638920" stop="72638920" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6849778</SubmissionName>
          <SubmissionName>SUB7605676</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="24259" SubmissionDate="2021-07-28" DateLastUpdated="2024-05-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606869.0001_TAY-SACHS DISEASE" title="HEXA, 4-BP INS, 1278TATC_TAY-SACHS DISEASE" />
        <ClinVarAccession Accession="SCV000024259" DateUpdated="2024-05-01" DateCreated="2013-04-04" Type="SCV" Version="67" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Affects</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Myerowitz and Costigan (1988) demonstrated that the most frequent DNA lesion in Tay-Sachs disease (272800) of Ashkenazi Jews is a homozygous 4-bp insertion in exon 11. This mutation introduces a premature termination signal in exon 11, resulting in a deficiency of mRNA. Using a dot-blot assay to screen patients and heterozygous carriers for the insertion mutation, Myerowitz and Costigan (1988) found the lesion in about 70% of carriers tested, thus identifying it as the most frequent defect underlying Tay-Sachs disease in the Ashkenazi Jewish population. Triggs-Raine and Gravel (1990) showed that this insertion mutation of only 4 bp can be detected by the formation of heteroduplexes. This mutation causes a frameshift and a termination codon 9 nucleotides downstream. By site-directed mutagenesis, Nishimoto et al. (1991) examined the basis of the paradox that the mutant gene with the 4-base insertion in exon 11 is transcribed normally but the mRNA is essentially undetectable. They found no evidence of interference with normal splicing of the transcript and the mutation did not destabilize properly spliced mRNA. Thus, the studies left open the question of the mechanism of the mutation. The possibility was mentioned that another still unidentified abnormality in the same allele may be responsible for the nearly complete absence of mRNA.</Attribute>
              <Citation>
                <ID Source="PubMed">2824459</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2294750</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">1830584</ID>
              </Citation>
              <XRef DB="OMIM" ID="272800" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">There appears to be an increased frequency of TSD in the Cajun population of southwest Louisiana which numbers less than one million persons. McDowell et al. (1992) reported that in the previous 3 decades, at least 8 infants from 6 apparently unrelated Cajun families had been identified. They found that the mutation in 11 of 12 of the TSD alleles in these 6 families was the exon 11 insertion present in approximately 70% of Ashkenazi Jewish TSD heterozygotes. The remaining allele was a single-base transition in the donor splice site of intron 9 (606869.0033). To trace the origins of these 2 mutations in the Cajun population, the TSD carrier status was determined enzymatically in 90 members of 4 of the 6 families, and extensive pedigrees were constructed for all carriers. A single ancestral couple from France was found to be common to most of the carriers of the exon 11 insertion. Pedigree data suggested that this mutation has been in the Cajun population since its founding and that it may be widely distributed within the population. In contrast, the intron 9 mutation was apparently introduced later and is probably limited to a few Louisiana families. Zlotogora (1993) argued that 2 mutations would not be unexpected in the Cajun population. Thurmon (1993) gave a historical account of the 'Jews of Acadiana.' He indicated that the Jews were assimilated into the Acadian culture and suggested that this was the source of the Tay-Sachs genes. He also pointed out that about the same time Jewish merchants began to arrive in Acadiana, the French Revolution produced an influx of non-Acadian French immigrants. Many were of aristocratic lineage and held themselves aloof from the Acadians.</Attribute>
              <Citation>
                <ID Source="PubMed">1307230</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8488832</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8352284</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">This mutation is alternatively designated 1277TATC or 1278insTATC. See 606869.0054.</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">To investigate the genetic history of the 1278insTATC mutation, the most frequent cause of Tay-Sachs disease in Ashkenazi Jews, Frisch et al. (2004) identified a conserved haplotype in 1278insTATC chromosomes for 55 unrelated Ashkenazi Jewish individuals (15 homozygotes and 40 heterozygotes for the TSD mutation), suggesting the occurrence of a common founder. When 2 methods were used for analysis of linkage disequilibrium (LD) between flanking polymorphic markers and the disease locus and for study of the decay of LD over time, the estimated age of the insertion was found to be 40 +/- 12 generations (95% confidence interval, 30 to 50 generations), so that the most recent common ancestor of the mutation-bearing chromosomes would date to the 8th or 9th century. This corresponds with the demographic expansion of Ashkenazi Jews in central Europe, following the founding of the Ashkenazi settlement in the early Middle Ages. The results were also consistent with the geographic distribution of the mutation and with the coalescent times of mutations causing 2 other lysosomal storage diseases frequent in Ashkenazi Jews: Gaucher disease (230800) and mucolipidosis IV (252650). Evidence for the absence of a heterozygote advantage of the mutation was provided by comparison between the estimated age of 1278insTATC and the probability of the current Ashkenazi Jewish frequency of the mutant allele as a function of its age, calculated by use of a branching-process model. Therefore, the founder effect in a rapidly expanding population arising from a bottleneck provides a robust and parsimonious hypothesis explaining the spread of 1278insTATC-related TSD in Ashkenazi Jewish individuals.</Attribute>
              <Citation>
                <ID Source="PubMed">14727180</ID>
              </Citation>
              <XRef DB="OMIM" ID="230800" Type="MIM" />
              <XRef DB="OMIM" ID="252650" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <Name>HEXA, 4-BP INS, 1278TATC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP INS, 1278TATC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606869.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TAY-SACHS DISEASE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3531875" SubmissionDate="2021-08-19" DateLastUpdated="2021-08-21" DateCreated="2021-08-21">
        <ClinVarSubmissionID localKey=":Chr.15_72638920_72638920_G_GGATA|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001798857" DateUpdated="2021-08-21" DateCreated="2021-08-21" Type="SCV" Version="1" SubmitterName="Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)" OrgID="506395" OrganizationCategory="laboratory" OrgAbbreviation="LDGA" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="GGATA" referenceAllele="G" start="72638920" stop="72638920" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10223652</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4902793" SubmissionDate="2022-05-05" DateLastUpdated="2022-05-16" DateCreated="2022-05-16">
        <ClinVarSubmissionID localKey="NM_000520.5:c.1274_1277dup" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002506704" DateUpdated="2022-05-16" DateCreated="2022-05-16" Type="SCV" Version="1" SubmitterName="New York Genome Center" OrgID="507558" OrganizationCategory="laboratory" OrgAbbreviation="NYGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">NYGC Assertion Criteria 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/hhfhf6ms/nygc_assertion_criteria_2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole genome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.5:c.1274_1277dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-NYCKidSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB11410540</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4949365" SubmissionDate="2022-06-14" DateLastUpdated="2022-06-18" DateCreated="2022-06-18">
        <ClinVarSubmissionID localKey="2107289|OMIM:272800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002526129" DateUpdated="2022-06-18" DateCreated="2022-06-18" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University Hospital Muenster" OrgID="507439" OrganizationCategory="clinic" OrgAbbreviation="IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG categories: PVS1,PS4,PP5,BS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Tissue>blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">20</Age>
              <Age Type="maximum" age_unit="years">29</Age>
              <AffectedStatus>no</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="GGATA" referenceAllele="G" start="72638920" stop="72638920" variantLength="1" />
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="387906309" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11612634</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5021700" SubmissionDate="2022-08-25" DateLastUpdated="2022-08-29" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="EATEF WES S10A|OMIM:272800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002567942" DateUpdated="2022-08-29" DateCreated="2022-08-29" Type="SCV" Version="1" SubmitterName="Daryl Scott Lab, Baylor College of Medicine" OrgID="505993" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.6:c.1274_1277dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">36135330</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11958415</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5041199" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_000520.6:c.1274_1277dup|OMIM:272800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002579636" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="387906309" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.6:c.1274_1277dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PM3, PM2_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5414226" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_000520_5_HEXA_c_1274_1277dupTATC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002768489" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Tay-Sachs disease (MIM#272800). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0305 - Variant is present in gnomAD (v2) &gt;=0.01 and &lt;0.03 for a recessive condition (210 heterozygotes, 0 homozygotes). (I) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. These variants have been reported many times as pathogenic (DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. It is one of the most common variants to cause Tay-Sachs disease in the Ashkenazi Jewish population (ClinVar). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_13789</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.5:c.1274_1277dupTATC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0010100" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="962833" SubmissionDate="2023-02-19" DateLastUpdated="2023-03-11" DateCreated="2016-01-31">
        <ClinVarSubmissionID localKey="16667|OMIM:272800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000328765" DateUpdated="2023-03-11" DateCreated="2016-01-31" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.6:c.1274_1277dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Dual_diagnosis_variants</SubmissionName>
          <SubmissionName>SUB12876118</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3966016" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="aa0364dfdcca77ef97cff3ff0fd6ec182db429549092b4b5d82d0127053343c1|OMIM:272800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002024978" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.6:c.1274_1277dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="395619" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2015-03-29">
        <ClinVarSubmissionID localKey="69899|MedGen:C0039373" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000218958" DateUpdated="2024-02-20" DateCreated="2015-03-29" Type="SCV" Version="11" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1833974</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8490625</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2848800</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16352452</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24518553</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25287655</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2848800</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22975760</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr427Ilefs*5) in the HEXA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HEXA are known to be pathogenic (PMID: 1833974, 8490625). This variant is present in population databases (rs387906309, gnomAD 1.3%), and has an allele count higher than expected for a pathogenic variant. This premature translational stop signal has been observed in individuals with Tay-Sachs disease (PMID: 2848800, 16352452, 20301397, 24518553, 25287655). It is commonly reported in individuals of Ashkenazi Jewish ancestry (PMID: 2848800, 22975760). This variant is also known as c.1277_1278insTATC. ClinVar contains an entry for this variant (Variation ID: 3889). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.72638920_72638921insGATA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0039373" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="530551" SubmissionDate="2016-05-19" DateLastUpdated="2016-06-09" DateCreated="2016-06-09">
        <ClinVarSubmissionID localKey="37095687" />
        <ClinVarAccession Accession="SCV000281445" DateUpdated="2016-06-09" DateCreated="2016-06-09" Type="SCV" Version="1" SubmitterName="Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics" OrgID="505698" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-06-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>Homo sapiens</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>Illumina</NamePlatform>
              <TypePlatform>Sequencing</TypePlatform>
              <ResultType>variant call</ResultType>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0.000561</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Insertion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" Strand="+" alternateAllele="GATA" referenceAllele="-" start="72638920" stop="72638921" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1334631" SubmissionDate="2017-12-18" DateLastUpdated="2017-12-26" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="127-20171218" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000680255" DateUpdated="2017-12-26" DateCreated="2017-12-26" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Tissue>blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
              <FamilyData PedigreeID="154" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">154</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Insertion</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="15" alternateAllele="GATA" referenceAllele="-" start="72638920" stop="72638921" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1363514" SubmissionDate="2018-01-25" DateLastUpdated="2017-12-26" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="NM_000520.4:c.1274_1277dupTATC|MedGen:C0039373" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000697162" DateUpdated="2017-12-26" DateCreated="2017-12-26" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-08-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24518553</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24374108</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2848800</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28503624</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22441121</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10571007</ID>
          </Citation>
          <Comment>Variant summary: This c.1274_1277dupTATC (p.Tyr427Ilefs) results in a premature termination codon, predicted to cause a truncated or absent HEXA protein due to nonsense mediated decay, which are commonly known mechanisms for disease. One functional study found less than 5% b-Hexosaminidase activity in leukocytes from a patient with Tay-Sachs disease carrying this variant in compound heterozygosity with p.R510H (not in our internal database)(Udwadia-Hedge_2017). This variant was found in the large control database ExAC in 92/121426 control chromosomes at a frequency of 0.0007577, which does not exceed the maximal expected frequency of a pathogenic allele (0.0013975) in this gene. This variant has been reported as a common pathogenic variant found especially in Ashkenazi Jews population with consistent clinical and genetic data (Myerowitz_1988, Jamali_2014, Zampieri_2012). Multiple clinical labs as well as reputable databases have classified this variant as pathogenic. Taken together, this variant has been classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="387906309" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.4:c.1274_1277dupTATC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0039373" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="413542" SubmissionDate="2016-11-03" DateLastUpdated="2019-07-31" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="3877_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000225230" DateUpdated="2019-07-31" DateCreated="2015-06-28" Type="SCV" Version="4" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-04-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">2848800</ID>
          </Citation>
          <Citation>
            <URL>http://omim.org/search?index=geneMap&amp;search=HEXA</URL>
          </Citation>
          <Citation>
            <URL>http://www.ncbi.nlm.nih.gov/sites/GeneTests/review/gene/HEXA</URL>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation Type="general">
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="7" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="5" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="GATA" referenceAllele="-" start="72638920" stop="72638921" variantLength="2" />
            <GeneLocation>NM_000520.4:Ex11</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI880091" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://geneticslab.emory.edu/emvclass/emvclass.php?approved_symbol=HEXA</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL003</SubmissionName>
          <SubmissionName>EGL004</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2808782" SubmissionDate="2020-07-14" DateLastUpdated="2020-07-27" DateCreated="2020-07-27">
        <ClinVarSubmissionID localKey="NM_000520.4:c.1274_1277dup|OMIM:272800;272750" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001424435" DateUpdated="2020-07-27" DateCreated="2020-07-27" Type="SCV" Version="1" SubmitterName="Centogene AG  - the Rare Disease Company" OrgID="279559" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.4:c.1274_1277dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272750" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>20200714_NPJ</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2818324" SubmissionDate="2020-05-05" DateLastUpdated="2020-08-17" DateCreated="2020-08-17">
        <ClinVarSubmissionID localKey="NM_000520.5:c.1274_1277dup|HPO:HP:0001249" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001428274" DateUpdated="2020-08-17" DateCreated="2020-08-17" Type="SCV" Version="1" SubmitterName="Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille" OrgID="505759" OrganizationCategory="laboratory" OrgAbbreviation="CHRUL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.5:c.1274_1277dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0001249" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7391912</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1100163" SubmissionDate="2021-07-15" DateLastUpdated="2021-07-16" DateCreated="2016-06-09">
        <ClinVarSubmissionID localKey="GDXSV:5943" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000565056" DateUpdated="2021-07-16" DateCreated="2016-06-09" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-07-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Common pathogenic variant in the HEXA gene found in the Ashkenazi Jewish population and associated with infantile onset Tay-Sachs disease (Kaback, M., 2011); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31980526, 31076878, 30548430, 28333917, 29352662, 27959697, 21228398, 28503624, 1307230, 2848800, 27033294, 8352284, 2294750, 1830584, 8488832, 14727180, 25287655, 22975760, 30609409)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:26008</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.4:c.1274_1277dupTATC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_15_20210715133136</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3863371" SubmissionDate="2021-09-21" DateLastUpdated="2021-10-07" DateCreated="2021-10-07">
        <ClinVarSubmissionID localKey=":Chr.15_72638920_72638920_G_GGATA|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001973862" DateUpdated="2021-10-07" DateCreated="2021-10-07" Type="SCV" Version="1" SubmitterName="Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center" OrgID="506497" OrganizationCategory="laboratory" OrgAbbreviation="CGDx-EMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="GGATA" referenceAllele="G" start="72638920" stop="72638920" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10405229</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4081401" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000520.6:c.1274_1277dup|Tay-Sachs disease" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002085670" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.6:c.1274_1277dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Tay-Sachs disease</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7544146" SubmissionDate="2023-09-08" DateLastUpdated="2023-09-09" DateCreated="2023-09-09">
        <ClinVarSubmissionID localKey="NM_000520.6:c.1274_1277dup|OMIM:272800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004032467" DateUpdated="2023-09-09" DateCreated="2023-09-09" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, Clinical Exome/Genome Diagnostics Group, University Hospital Bonn" OrgID="508040" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.6:c.1274_1277dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13825193</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7926697" SubmissionDate="2024-02-02" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4107446_NM_000520.6:c.1274_1277dup|OMIM:272800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004242410" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Criteria applied: PVS1,PM3_VSTR,PM2_SUP</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001513" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002015" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0100022" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002421" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002376" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0004322" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001252" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0031165" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0011344" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.6:c.1274_1277dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14199545</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1446816" SubmissionDate="2024-04-19" DateLastUpdated="2024-05-01" DateCreated="2018-04-15">
        <ClinVarSubmissionID localKey="a573|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000743019" DateUpdated="2024-05-01" DateCreated="2018-04-15" Type="SCV" Version="5" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">2848800</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8230592</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20672374</ID>
          </Citation>
          <Comment>The c.1274_1277dupTATC (p.Y427Ifs*5) alteration, located in coding exon 11 of the HEXA gene, consists of a duplication of TATC at position 1274, causing a translational frameshift with a predicted alternate stop codon after 5 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, this allele has an overall frequency of 0.07% (210/282850) total alleles studied. The highest observed frequency was 1.29% (134/10370) of Ashkenazi Jewish alleles. This mutation is the most common Tay-Sachs disease alteration found in the Ashkenazi Jewish population (Myerowitz, 1988) and has been shown to account for approximately 80% of all mutant HEXA Ashkenazi Jewish alleles (Kaback, 1993; Scott, 2010). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.4:c.1274_1277dupTATC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_1</SubmissionName>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
          <SubmissionName>exome clinvar deposit 2.18.18</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9762581" SubmissionDate="2024-05-02" DateLastUpdated="2024-05-12" DateCreated="2024-05-12">
        <ClinVarSubmissionID localKey="3039002387" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005042632" DateUpdated="2024-05-12" DateCreated="2024-05-12" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The frameshift c.1274_1277dup p.Tyr427IlefsTer5 variant in HEXA gene has been previously reported in homozygous and compound heterozygous states in multiple individuals affected with GM2 gangliosidoses Scott et al., 2010; Zampieri et al., 2012; Jamali et al., 2014. The p.Tyr427IlefsTer5 variant has been reported with allele frequency of 0.07% in gnomAD Exomes and is novel not in any individuals in 1000 Genomes. This variant has been reported to the ClinVar database as Pathogenic multiple submissions. This variant causes a frameshift starting with codon Tyrosine 427, changes this amino acid to Isoleucine residue, and creates a premature Stop codon at position 5 of the new reading frame, denoted p.Tyr427IlefsTer5. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000520.6:c.1274_1277dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14421073</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3438477" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2021-07-10">
        <ClinVarSubmissionID localKey="107143|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001747734" DateUpdated="2024-07-15" DateCreated="2021-07-10" Type="SCV" Version="17" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>HEXA: PVS1, PM2, PM3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="GGATA" referenceAllele="G" start="72638920" stop="72638920" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="966546" TraitType="Finding" MappingType="Name" MappingValue="Hepatomegaly" MappingRef="Preferred">
        <MedGen CUI="C0019209" Name="Hepatomegaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926697" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001252" MappingRef="HP">
        <MedGen CUI="C0026827" Name="Hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="413542" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2253889" TraitType="Disease" MappingType="Name" MappingValue="Tay-Sachs disease" MappingRef="Preferred">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1446816" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926697" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004322" MappingRef="HP">
        <MedGen CUI="C0349588" Name="Short stature" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7544146" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="966546" TraitType="Finding" MappingType="Name" MappingValue="Muscular hypotonia" MappingRef="Preferred">
        <MedGen CUI="C0026827" Name="Hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3531875" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="966546" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="966546" TraitType="Finding" MappingType="Name" MappingValue="Developmental regression" MappingRef="Preferred">
        <MedGen CUI="C1836830" Name="Developmental regression" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="395619" TraitType="Disease" MappingType="XRef" MappingValue="C0039373" MappingRef="MedGen">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1789760" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2818324" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001249" MappingRef="HP">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926697" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002015" MappingRef="HP">
        <MedGen CUI="C0011168" Name="Dysphagia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3966016" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4081401" TraitType="Disease" MappingType="Name" MappingValue="Tay-Sachs disease" MappingRef="Preferred">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1334631" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2354320" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2808782" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="966546" TraitType="Finding" MappingType="Name" MappingValue="Seizures" MappingRef="Preferred">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926697" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4949365" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3438477" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="966546" TraitType="Finding" MappingType="Name" MappingValue="Abnormal thalamic MRI signal intensity" MappingRef="Preferred">
        <MedGen CUI="C4022770" Name="Abnormal thalamic MRI signal intensity" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4902793" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926697" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002421" MappingRef="HP">
        <MedGen CUI="C1836038" Name="Poor head control" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="962833" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3863371" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1139224" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926697" TraitType="Finding" MappingType="XRef" MappingValue="HP:0100022" MappingRef="HP">
        <MedGen CUI="C0026650" Name="Movement disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="459193" TraitType="Disease" MappingType="Name" MappingValue="Tay-Sachs disease" MappingRef="Preferred">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1363514" TraitType="Disease" MappingType="XRef" MappingValue="C0039373" MappingRef="MedGen">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="966546" TraitType="Finding" MappingType="Name" MappingValue="Hyperacusis" MappingRef="Preferred">
        <MedGen CUI="C0034880" Name="Hyperacusis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24259" TraitType="Disease" MappingType="Name" MappingValue="TAY-SACHS DISEASE" MappingRef="Preferred">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2808782" TraitType="Disease" MappingType="XRef" MappingValue="272750" MappingRef="OMIM">
        <MedGen CUI="C0268275" Name="Tay-Sachs disease, variant AB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5021700" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926697" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011344" MappingRef="HP">
        <MedGen CUI="C1837397" Name="Severe global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926697" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002376" MappingRef="HP">
        <MedGen CUI="C1836830" Name="Developmental regression" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926697" TraitType="Finding" MappingType="XRef" MappingValue="HP:0031165" MappingRef="HP">
        <MedGen CUI="C3281034" Name="Multifocal seizures" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1048752" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="966546" TraitType="Finding" MappingType="Name" MappingValue="EEG abnormality" MappingRef="Preferred">
        <MedGen CUI="C0151611" Name="EEG abnormality" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9762581" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4902793" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5041199" TraitType="Disease" MappingType="XRef" MappingValue="272800" MappingRef="OMIM">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926697" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001513" MappingRef="HP">
        <MedGen CUI="C0028754" Name="Obesity" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1393311" TraitType="Disease" MappingType="Name" MappingValue="Tay-Sachs disease" MappingRef="Preferred">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="530551" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1100163" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="966546" TraitType="Finding" MappingType="Name" MappingValue="Cherry red spot of the macula" MappingRef="Preferred">
        <MedGen CUI="C2216370" Name="Cherry red spot of the macula" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5414226" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0010100" MappingRef="MONDO">
        <MedGen CUI="C0039373" Name="Tay-Sachs disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

